Stryker (NYSE:SYK) Price Target Increased to $375.00 by Analysts at Stifel Nicolaus

Stryker (NYSE:SYK – Free Report) had its price objective boosted by Stifel Nicolaus from $350.00 to $375.00 in a report issued on Wednesday, Benzinga reports. Stifel Nicolaus currently has a buy rating on the medical technology company’s stock. Other equities research analysts also recently issued research reports about the company. Wells Fargo & Company upped […]

Related Keywords

Canada ,Allanc Golston ,Robertw Baird ,Stifel Nicolaus ,Williame Berry Jr ,Aspen Investment Management Inc ,Portfolio Review Corp ,Bremer Bank National Association ,Simon Quick Advisors ,Wells Fargo Company ,Harbor Investment Advisory ,Royal Bank ,Stryker Corporation ,Canaccord Genuity Group ,Securities Exchange Commission ,Stryker Company Profile ,Free Report ,Genuity Group ,Moderate Buy ,Get Free Report ,Director Allan ,Exchange Commission ,Investment Management Inc ,Investment Advisory ,Bank National Association ,Quick Advisors ,Consolidated Portfolio Review Corp ,Stryker Daily ,Stryker ,Nyse Syk ,Syk ,Medical ,86366710 ,Boost Price Target ,